Intarcia Therapeutics (United States)
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Intarcia Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
57%
Total
Publications
86
Total Open
Publications
49
Total
Citations
3.5K
Open Access
Percentage
57%
Total
Publications
86
Total Open
Publications
49
Total
Citations
3.5K
Breakdown
Publisher Open
22%
Both
27%
Other Platform Open
8%
Closed
43%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
12
Hybrid 31%
13
No Guarantees 40%
17
Other Platform Open
Domain 70%
21
Institution 27%
8
Other Internet 23%
7
Preprint 20%
6
Public 3%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
DOI | Other Internet | 49 |
PubMed Central | Domain | 21 |
Europe PMC | Domain | 8 |
bioRxiv | Preprint | 5 |
University College London - UCL Discovery | Institution | 2 |
The Deutsches Elektronen-Synchrotron - Desy publication database | Institution | 2 |
University of North Carolina at Chapel Hill - Carolina Digital Repository | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
Max Planck Society - MPG.PuRe | Institution | 1 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 1 |